2021-04-16 04:06:20 GMT2021-04-16 12:06:20(Beijing Time) Xinhua English
SYDNEY, April 16 (Xinhua) An Australia-led international study has found that patients with overweight or obese were at high risk of having worse COVID-19 outcomes.
The recent research, led by the Murdoch Children s Research Institute (MCRI) and the University of Queensland and published in Diabetes Care, found that those patients were also more likely to require oxygen and invasive mechanical ventilation compared to those with a healthy weight.
The study looked at 7,244 adult patients hospitalized with COVID-19 from 18 hospitals in 11 countries, among whom 34.8 percent were overweight and 30.8 percent were obese.
They found that COVID-19 patients with obesity were more likely to require oxygen and had a 73 percent greater chance of needing invasive mechanical ventilation. Similar but more modest results were seen in overweight patients.
What tough choices are ahead as we learn to live with Covid
getsurrey.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from getsurrey.co.uk Daily Mail and Mail on Sunday newspapers.
What tough choices are ahead as we learn to live with Covid
grimsbytelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from grimsbytelegraph.co.uk Daily Mail and Mail on Sunday newspapers.
What tough choices are ahead as we learn to live with Covid
leicestermercury.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leicestermercury.co.uk Daily Mail and Mail on Sunday newspapers.
China s Sinovac COVID-19 vaccine produced by Chinese company Sinovac Biotech works well with clinical coronavirus symptoms, especially in moderate-to-severe cases, Bloomberg News reported on Tuesday.
The efficacy data of about 50 percent of the vaccine is for very mild disease, requiring no treatment, Fiona Russell from the Murdoch Children s Research Institute in Melbourne was quoted as saying.
For infections requiring some medical intervention, it is about 84 percent and for moderate-to-severe COVID cases, it is 100 percent, Russell said.
Paul Griffin, a professor from the University of Queensland in Brisbane, told Bloomberg that if the vaccine is approved by relevant regulators, then I think we need to have faith that it s safe and effective in that population.